Regeneron pharmaceuticals, inc. (REGN)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Sep'09Jun'09
Revenues [Abstract]
Revenues

8,319

7,863

7,282

6,897

6,571

6,710

6,365

6,202

6,064

5,872

5,516

5,236

4,978

4,860

4,731

4,648

4,434

4,103

3,807

3,396

3,063

2,819

2,627

2,498

2,290

2,104

1,908

1,739

1,586

1,378

1,086

761

565

445

456

459

467

459

442

426

0

0

0

Sanofi collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

649

-

693

773

805

758

728

636

584

541

516

518

461

430

423

434

438

423

396

330

326

326

331

327

327

311

297

282

0

0

0

Bayer Collaboration Revenue

-

-

-

-

-

-

-

-

-

-

-

-

758

-

727

693

636

580

552

531

494

495

444

396

330

220

156

94

72

70

57

41

43

43

68

72

74

75

72

71

0

0

0

Other revenue

-

-

-

-

-

-

-

-

-

-

-

-

158

-

85

76

64

74

65

55

52

31

31

29

29

28

29

28

27

26

30

30

29

31

29

33

37

40

40

40

0

0

0

Other revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

6

7

7

6

7

7

0

0

0

Expenses:
Research and development

3,134

3,036

2,799

2,692

2,173

2,186

2,112

2,085

2,066

2,075

2,026

2,039

2,089

2,052

2,034

1,917

1,747

1,620

1,511

1,422

1,327

1,271

1,187

1,074

967

859

772

707

666

625

573

543

538

529

525

519

501

489

469

441

0

0

0

Selling, general, and administrative

1,911

1,834

1,619

1,569

1,516

1,556

1,474

1,412

1,354

1,320

1,236

1,199

1,184

1,177

1,146

1,086

969

838

718

652

575

519

443

396

372

346

305

254

229

210

189

175

152

117

101

84

74

65

57

53

0

0

0

Other operating (income) expense, net

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total expenses

5,889

5,653

5,030

4,757

4,124

4,176

4,010

3,914

3,848

3,792

3,628

3,545

3,546

3,529

3,516

3,404

3,137

2,851

2,571

2,363

2,147

1,995

1,824

1,647

1,509

1,361

1,215

1,080

997

920

820

756

707

650

629

605

577

556

528

497

0

0

0

Income from operations

2,429

2,209

2,252

2,140

2,447

2,534

2,355

2,288

2,216

2,079

1,887

1,690

1,431

1,330

1,214

1,244

1,297

1,251

1,236

1,032

915

823

803

851

781

743

693

659

588

457

266

5

-141

-205

-172

-146

-109

-97

-85

-70

0

0

0

Other income (expense):
Other (expense) income, net

150

249

-5

-27

96

47

103

99

39

24

-0

-8

12

6

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

2

2

1

2

2

2

3

3

3

3

2

2

2

3

0

0

0

Interest and other expense, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

28

30

31

30

29

28

26

25

23

25

30

23

17

7

0

0

0

-

-

-

-

-37

42

45

46

46

46

45

45

45

43

35

28

21

14

12

10

9

7

5

0

0

0

Loss on Extinguishment of Debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10

-10

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income (expense)

121

219

-36

-57

67

19

77

73

15

-1

-22

-25

0

-0

0

-1

-18

-26

-49

-56

-59

-62

-50

-55

-46

-46

-43

-43

-43

-43

-40

-33

-25

-17

-10

-9

-8

-6

-4

-1

0

0

0

Income before income taxes

2,551

2,429

2,215

2,082

2,514

2,553

2,432

2,361

2,231

2,078

1,865

1,665

1,431

1,329

1,215

1,242

1,278

1,225

1,187

976

856

761

752

796

735

696

649

615

544

414

225

-27

-167

-222

-183

-155

-117

-104

0

0

0

-

-

Income tax expense

272

313

71

13

86

109

634

770

804

880

587

510

468

434

418

499

537

589

616

531

511

423

418

404

352

282

-148

-232

-292

-335

-0

-0

-0

-1

-0

-1

-0

0

0

0

0

-

-

Net Income (Loss) Attributable to Parent

2,279

2,115

2,144

2,069

2,427

2,444

1,797

1,591

1,427

1,198

1,278

1,154

963

895

797

742

741

636

571

444

345

338

334

392

383

413

797

848

837

750

226

-27

-166

-221

-182

-154

-117

-104

-90

-71

0

0

0

Net income per share - basic (in dollars per share)

5.69

7.26

6.12

1.77

4.23

7.59

5.50

5.12

4.44

1.61

3.64

3.66

2.36

2.40

2.53

1.88

1.74

1.50

2.04

1.89

0.74

0.88

0.83

0.96

0.69

0.88

1.44

0.89

1.02

4.97

2.02

0.81

0.12

-0.59

-0.68

-0.69

-0.49

-

-

-

-

-

-

Net income per share - diluted (in dollars per share)

5.43

6.93

5.86

1.68

3.99

7.14

5.17

4.82

4.16

1.52

3.32

3.34

2.16

2.15

2.27

1.69

1.59

1.35

1.82

1.69

0.66

0.79

0.73

0.85

0.61

0.78

1.25

0.79

0.90

4.22

1.72

0.70

0.11

-0.59

-0.68

-0.69

-0.49

-

-

-

-

-

-

Weighted average shares outstanding - basic (in shares)

109

109

109

109

108

108

108

107

107

106

106

106

105

105

104

104

104

103

103

102

102

102

100

100

98

98

98

97

96

95

95

94

93

91

91

90

89

-

-

-

-

-

-

Weighted Average Number of Shares Outstanding, Diluted

115

114

114

114

115

114

115

114

114

115

117

116

115

118

116

116

114

115

115

115

114

111

117

113

112

108

116

111

109

127

115

110

107

91

91

90

89

-

-

-

-

-

-

Other comprehensive income (loss), net of tax:
Unrealized (loss) gain on debt securities

-9

35

31

31

20

-7

-30

-10

-5

12

26

-2

-10

-21

-10

-13

-43

-43

-19

14

46

53

29

7

3

-0

-0

-1

-0

0

-0

-1

0

0

0

0

0

-

-

-

-

-

-

Unrealized loss on cash flow hedges

-2

-2

-4

-3

-1

0

3

2

2

0

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive income

2,267

2,149

2,171

2,096

2,446

2,438

1,769

1,583

1,424

1,212

1,304

1,151

952

874

786

729

697

592

551

459

392

391

363

399

386

413

797

847

837

750

226

-28

-165

-221

0

0

0

-

-

-

-

-

-

Net loss per share, basic and diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.41

-0.31

-0.38

-0.01

-0.19

Weighted average shares outstanding, basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

81

81

81

0

0

Product
Revenues

4,966

4,834

4,644

4,431

4,222

4,106

3,988

3,920

3,848

3,718

3,602

3,502

3,412

3,338

3,225

3,105

2,929

2,689

2,461

2,172

1,932

1,750

1,635

1,553

1,469

1,425

1,301

1,183

1,048

858

606

362

168

44

20

19

19

25

24

24

0

0

0

Cost of goods sold

370

362

297

212

181

180

188

204

210

202

194

177

176

194

221

258

278

241

208

175

144

129

125

120

117

118

113

105

99

83

57

37

16

4

1

1

1

2

1

2

0

0

0

Collaboration and contract manufacturing
Cost of goods sold

457

419

370

339

309

254

234

212

217

194

171

128

95

105

114

142

142

151

132

112

101

75

68

56

52

37

23

13

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-